Fertility Madrid
- Address
- C/ General Oráa 47, 28006 Madrid, Spain
Fertility Madrid - Maternal Health Research Center
Fertility Madrid is a specialized reproductive medicine and maternal health research center dedicated to advancing care for pregnant women and improving outcomes during pregnancy. The center focuses on evidence-based interventions that enhance the quality of life and wellbeing of expectant mothers throughout their pregnancy journey.
- Nausea and vomiting of pregnancy (NVP) management and treatment optimization
- Quality of life assessment in pregnant women
- Pharmaceutical interventions for pregnancy-related conditions
Through prospective, multicentre clinical trials, the center evaluates innovative therapeutic approaches for common pregnancy complications. Current research includes investigating fixed-dose combination therapies such as doxylamine and pyridoxine for managing nausea and vomiting of pregnancy, with a particular emphasis on measuring treatment efficacy through validated quality of life metrics. This patient-centered approach ensures that therapeutic interventions not only address clinical symptoms but also meaningfully improve the daily experiences of pregnant women.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fertility Madrid
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Doxylamine Hydrogen Succinate and Pyridoxine Hydrochloride in Pregnant Women with Nausea and Vomiting: A Multicenter, Open-Label Study | Itf Research Pharma S.L. | Phase III | Not Recruiting | Oct 2023 | Aug 2024 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Doxylamine Hydrogen Succinate | 1 | Unknown | 2023-10-31 | 2023-10-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.